Rohto Pharmaceutical and Nichi Nichi Pharmaceutical Confirm that Lactic Acid Bacteria Preparation LFK Helps Inhibit (Japan Corporate News)
Tokyo (JCNN) - On June 8, Rohto Pharmaceutical (TSE: 4527) announced the results of its latest research co-conducted with Nichi Nichi Pharmaceutical on lysed Enterococcus faecalis FK-23 (LFK), a kind of lactic acid bacteria preparation.
